IOVS Am. J. Pathology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2004;45:4491-4497.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-0172
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Apte, R. S.
Right arrow Articles by Ferguson, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Apte, R. S.
Right arrow Articles by Ferguson, T. A.

Stimulation of Neovascularization by the Anti-angiogenic Factor PEDF

Rajendra S. Apte,1 Ramon A. Barreiro,1 Elia Duh,2 Olga Volpert,3 and Thomas A. Ferguson1

1From the Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri; 2The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and the 3Department of Urology, Northwestern University Medical School, Chicago, Illinois.

PURPOSE. Examine the effect of (pigment epithelium–derived growth factor; PEDF) on laser-induced choroidal neovascularization (CNV).

METHODS. Adult C57Bl/6 mice were anesthetized and four laser spots were placed in each quadrant of the fundus with a krypton red laser (614 nm, 50 µm, 0.05 second, 200 mW). Animals were treated with various doses of PEDF administered with miniosmotic pumps implanted subcutaneously. Seven days after laser treatment, mice were perfused with 3% FITC high-molecular-weight dextran, the eyes enucleated, and neovascularization analyzed by confocal microscopy. Data were recorded as the volume of the neovascular complex. The effect of PEDF on endothelial cell migration, vascular tube formation in synthetic basement membrane, and VEGF production was also determined.

RESULTS. Mice receiving a lower dose of PEDF (90 µg/mL) had significantly decreased areas of CNV. A high dose of PEDF (360 µg/mL) significantly increased CNV, whereas an intermediate dose (180 µg/mL) of PEDF had no effect. PEDF inhibited endothelial cell migration and vascular tube formation at lower doses (0.5–5 µg/mL). High doses of PEDF (25–50 µg/mL) stimulated endothelial cell migration, enhanced vascular tube formation in vitro, and stimulated VEGF production from endothelial cells. Neutralizing anti-VEGF antibody completely reversed the stimulatory effects of high doses of PEDF on CNV in vivo.

CONCLUSIONS. PEDF demonstrates opposing effects on CNV and endothelial cell function. Whereas low doses are inhibitory, high doses can augment the development of the neovasculature. These results suggest that the effects of PEDF on neovascularization are more complex than originally believed and that caution should be exercised when PEDF therapies are considered.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
Y. Mirochnik, A. Aurora, F. T. Schulze-Hoepfner, A. Deabes, V. Shifrin, R. Beckmann, C. Polsky, and O. V. Volpert
Short Pigment Epithelial-Derived Factor-Derived Peptide Inhibits Angiogenesis and Tumor Growth
Clin. Cancer Res., March 1, 2009; 15(5): 1655 - 1663.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Campos, J. Amaral, S. P. Becerra, and R. N. Fariss
A Novel Imaging Technique for Experimental Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5163 - 5170.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. Banin, M. I. Dorrell, E. Aguilar, M. R. Ritter, C. M. Aderman, A. C. H. Smith, J. Friedlander, and M. Friedlander
T2-TrpRS Inhibits Preretinal Neovascularization and Enhances Physiological Vascular Regrowth in OIR as Assessed by a New Method of Quantification
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 2125 - 2134.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. A. Campochiaro and the First ARVO/Pfizer Institute Working Group
Ocular versus Extraocular Neovascularization: Mirror Images or Vague Resemblances
Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 462 - 474.
[Full Text] [PDF]

Home page
 IOVSHome page
J. Amaral, R. N. Fariss, M. M. Campos, W. G. Robison Jr, H. Kim, R. Lutz, and S. P. Becerra
Transscleral-RPE Permeability of PEDF and Ovalbumin Proteins: Implications for Subconjunctival Protein Delivery
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4383 - 4392.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. Notari, A. Miller, A. Martinez, J. Amaral, M. Ju, G. Robinson, L. E. H. Smith, and S. P. Becerra
Pigment Epithelium-Derived Factor Is a Substrate for Matrix Metalloproteinase Type 2 and Type 9: Implications for Downregulation in Hypoxia
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2736 - 2747.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology